Elite Pharmaceuticals, Inc. Share Price Other OTC
Equities
ELTP
US28659T2006
Pharmaceuticals
Sales 2022 | 32.26M 2.57B | Sales 2023 | 34.16M 2.72B | Capitalization | 29.4M 2.35B |
---|---|---|---|---|---|
Net income 2022 | 8M 638M | Net income 2023 | 3M 239M | EV / Sales 2022 | 0.92 x |
Net cash position 2022 | 5.75M 459M | Net cash position 2023 | 3.94M 315M | EV / Sales 2023 | 0.75 x |
P/E ratio 2022 |
4.73
x | P/E ratio 2023 |
9.34
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.76% |
Latest transcript on Elite Pharmaceuticals, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Nasrat Hakim
CEO | Chief Executive Officer | 63 | 31/07/13 |
Carter Ward
DFI | Director of Finance/CFO | 59 | 30/06/09 |
Christopher Dick
PSD | President | 69 | 31/10/02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Whitnell
BRD | Director/Board Member | 68 | 22/10/09 |
Barry Dash
BRD | Director/Board Member | 93 | 31/03/05 |
Davis Caskey
BRD | Director/Board Member | 76 | 27/04/16 |
1st Jan change | Capi. | |
---|---|---|
+19.27% | 43.18B | |
+24.05% | 23.23B | |
+15.11% | 14.6B | |
+38.36% | 11.5B | |
-7.63% | 6.79B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.31B | |
-2.27% | 4.81B |